By BY CHRISTINA JEWETT, CARL ZIMMER AND REBECCA ROBBINS from NYT Health
https://ift.tt/32c63fc
The single remaining monoclonal antibody therapy effective against the variant is now in short supply in the U.S., imperiling an option that doctors and hospitals have relied on.
No comments:
Post a Comment